# Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors

> **NCT00752947** · PHASE4 · UNKNOWN · sponsor: **Beijing Hospital** · enrollment: 186 (estimated)

## Conditions studied

- Community-Acquired Pneumonia

## Interventions

- **DRUG:** moxifloxacin
- **DRUG:** levofloxacin
- **DRUG:** metronidazole

## Key facts

- **NCT ID:** NCT00752947
- **Lead sponsor:** Beijing Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2010-03
- **Final completion:** 2010-05
- **Target enrollment:** 186 (ESTIMATED)
- **Last updated:** 2009-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00752947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00752947, "Efficacy and Safety Trial to Assess Moxifloxacin in Treating Community-Acquired Pneumonia (CAP) With Aspiration Factors". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00752947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*